Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil state Minas Gerais bans emamectin use

The Brazilian state of Minas Gerais has banned the application of the insecticide, emamectin benzoate, for the control of earworms (Helicoverpa armigera). The state's agriculture office, the IMA, has followed the advice of the state public prosecutor following its impact study of the active ingredient's use, national media report. The IMA justifies its move noting: its isolation policy of leaving land fallow for a period between plantings of cotton, beans and soybeans; the employment of agronomy inspectors in the fields; and the registration of 18 products for earworm control. Minas Gerais is among at least six Brazilian states to have declared a state of emergency due to infestations of the pest. The import and use of emamectin is among the measures such states may implement under emergency regulations (Agrow No 677, p 17). The public prosecutor in major Brazilian soybean growing state Mato Grosso also recommends that the ai not be permitted in that state (Agrow No 681, p 17).

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG001096

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel